LC/MS/MS Method Package for Short Chain Fatty Acids
For LabSolutions™ LCMS Software
Short-Chain Fatty Acids and Organic Acids Targeted for Analysis
Of the short-chain fatty acids produced by intestinal bacteria, acetic acid, propionic acid, and butyric acid are well known, and it has been reported that there are some connections between them and lifestyle-related diseases such as obesity and diabetes. Generally speaking, short-chain fatty acids are highly volatile and highly hydrophilic. This makes it difficult to perform LCMS analysis using a conventional reverse phase system. For that reason, this method package targets short-chain fatty acids (C2 to C5) that have been derivatized using 3-nitrophenylhydrazine (3-NPH). After setting MRM transitions, it can be used for the simultaneous analysis (of 22 components), including organic acids related to the central metabolic pathways.
|
|
MRM Transition Settings
When making MRM transition settings, selectivity can be enhanced by specifying characteristic product ions for 3-nitrophenylhydrazine derivatives. Note that some organic acids have a carbonyl group derived from ketones, so 3-nitrophenylhydrazine derivatives that reacted with carboxylic acid and the carbonyl group are targeted for MRM transition.
Pretreatment Protocol Including Derivatization
The entire protocol necessary for pretreatment, including the derivatization step using 3-nitrophenylhydrazine, is contained in the Instruction Manual for this method package. By following these procedures, an analyst should be able to perform the entire process, from derivatization to data acquisition and data analysis, immediately after the package is introduced.
For the derivatization using 3-nitrophenylhydrazine, carbodiimide is used as a condensing agent, and reaction proceeds under mild conditions. Moreover, in order to efficiently carry out reactions with both short-chain fatty acids and organic acids, this method package includes derivatization using 3-NPH instead of the more commonly used 2-NPH. Also, 3-NPH derivatizations after reactions are stable, and quantitative analysis of the short-chain fatty acids or organic acids in the sample can be performed through reaction with an appropriate amount of derivatization reagent. Additionally, as reactions take place in water solutions using this derivatization reagent, the sample will not be dried and volatile components will not be lost.
Derivatization Reaction with 3-nitrophenylhydrazine (3-NPH)
The following example shows an analysis using the LCMS-8060 of a standard mixed solution of short-chain fatty acids/organic acids. An MRM chromatogram of short-chain fatty acids/organic acids derivatized using 3-NPH is shown. As can be seen, sufficient separations of the components, such as the structural isomers butyric acid, isobutyric acid, fumaric acid, maleic acid, citric acid, and isocitric acid were obtained. This method package includes MRM transitions that were formulated beforehand in order to achieve optimization for 3-NPH derivatizations for short-chain fatty acids/organic acids. As a result, short-chain fatty acids (C2 to C5) and organic acids representative of central metabolic pathways, which are difficult to analyze with LCMS using a conventional reversed phase system, can be analyzed simultaneously.
Remarks and Precautions
LabSolutions LCMS Ver. 5.99SP2 or later is required.
LabSolutions is a trademark of Shimadzu Corporation.
News / Events
-
New High Resolution Accurate Mass Library for Forensic Toxicology
Perform forensic toxicology screening for drugs of abuse, psychotropic drugs, pharmaceuticals, pesticides, and natural toxins using this high-resolution accurate mass database.
-
Shimadzu has released the Shim-vial™ H glass, S glass.
Shimadzu provides high-quality vials that thoroughly eliminate these risks by visually inspecting each vial, allowing them to be used with confidence.
-
INTERNATIONAL MASS SPECTROMETRY CONFERENCE 2024
Visit the Shimadzu booth at the International Mass Spectrometry Conference (IMSC) 2024.
-
Metabolomics 2024
Shimadzu Lunch Presentation at Metabolomics 2024
Date: June 20th, 2024 (Thursday)
Time: 12:25 – 1:25 p.m. -
New LabSolutions Insight Biologics
Supporting Innovation with Oligonucleotide Therapeutics
-
Shimadzu has released the LCMS-TQ RX Series High-Performance Liquid Chromatograph Mass Spectrometers
Innovative technology, exceptional design and new ways of thinking are part of our engineering DNA delivering solutions for the ever-changing needs of any laboratory. As our scientific and business needs change our engineering design evolves and adapts. The result is the RX Series of triple quadrupole LC-MS instruments designed with unmatched capability, redefined reliability and creating a new standard in actionable data.